Ani Pharmaceuticals reported $344.26M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ani Pharmaceuticals ANIP:US USD 344.26M 34.88M
Aurora Cannabis Inc ACB:CN CAD 542.79M 139.04M
Canopy Growth Corp WEED:CN CAD 1.17B 365.26M
Depomed DEPO:US USD 132.26M 5.77M
Emergent Biosolutions EBS:US USD 1.21B 92.2M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Hikma Pharmaceutical HIK:LN USD 2B 145M
Knight Therapeutics Inc GUD:CN CAD 395.62M 52.77M
Lannett LCI:US USD 250.53M 14.13M
Nektar Therapeutics NKTR:US USD 545.97M 53.52M
Novartis NVS:US USD 36.91B 44M
Omeros OMER:US USD 443.24M 154.69M
Perrigo Ordinary Shares PRGO:US USD 2.72B 136.6M
Teva Pharmaceutical TEVA:IT USD 12.05B 598M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M